Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

ClinicalTrials.gov ID: NCT01371578

Public ClinicalTrials.gov record NCT01371578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 11:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy Using Combinations of Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection (Protocol GS US 256 0124)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating Response Guided Therapy using Combinations of Oral Antivirals (GS-5885, tegobuvir, and/or GS-9451) with Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects with Chronic Genotype 1 Hepatitis C Virus (HCV) Infection.

Study identification

NCT ID
NCT01371578
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
163 participants

Conditions and interventions

Interventions

Drug · Biological

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2011 (Type not available)
Primary completion
Mar 2013 (Actual)
Completion
Mar 2013 (Actual)
Last update posted
Feb 11, 2014

2011 – 2013

United States locations

U.S. sites
54
U.S. states
23
U.S. cities
46
Facility City State ZIP Site status
Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
Alabama Liver and Digestive Specialists Montgomery Alabama 36116 —
California Liver Institute Beverly Hills California 90211 —
Scripps Clinic La Jolla California 92037 —
University of California Davis Medical Center Sacramento California 95817 —
RESEARCH and EDUCATION, INC San Diego California 92015 —
Medical Associates Research Group San Diego California 92123 —
Kaiser Permanente San Diego California 92154 —
University of Colorado Denver Aurora Colorado 80045 —
South Denver Gastroenterology Englewood Colorado 80110 —
Bach and Godofsky Infectious Diseases Bradenton Florida 34209 —
University of Florida Gainesville Florida 32610 —
University of Miami Miami Florida 33136 —
Orlando Immunology Center Orlando Florida 32803 —
South Florida Center of Gastroenterology, LLC Wellington Florida 33414 —
Emory University, Infectious Disease Clinic Atlanta Georgia 30308 —
Digestive Healthcare of Georgia Atlanta Georgia 30309 —
Dekalb Gastroenterology Decatur Georgia 30033 —
Gastrointestinal Specialists of Georgia PC Marietta Georgia 30060 —
Indiana University Indianapolis Indiana 46202 —
Indianapolis Gastroenterology Research Foundation Indianapolis Indiana 46237 —
Graves Gilbert Clinic Bowling Green Kentucky 42101 —
Gastroenterology Associates, LLC Baton Rouge Louisiana 70809 —
Digestive Disease Associates, PA Baltimore Maryland 21229 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 —
Partners in Internal Medicine, P.C. Worcester Massachusetts 01608 —
Henry Ford Health System Detroit Michigan 48202 —
Gastrointestinal Associates, PA Jackson Mississippi 39202 —
Digestive Health Specialists, PA Tupelo Mississippi 38801 —
ID Care 105 Hillsborough New Jersey 08844 —
Atlantic Research Affiliates, LLC Morristown New Jersey 07960 —
Southwest CARE Center Santa Fe New Mexico 87505 —
Binghamton Gastroenterology Binghamton New York 13903 —
North Shore University Hospital Manhasset New York 11030 —
Concorde Medical Group New York New York 10016 —
Cornell University Gastroenterology & Hepatology New York New York 10021 —
Asheville Gastroenterology Associates, P.A. Asheville North Carolina 28801 —
Duke University Medical Center Durham North Carolina 27710 —
Cumberland Research Associates, LLC Fayetteville North Carolina 28304 —
University of Cincinnati Cincinnati Ohio 45267 —
Options Health Research, LLC Tulsa Oklahoma 74104 —
University Gastroenterology Providence Rhode Island 02905 —
Memphis Gastroenterology Group Germantown Tennessee 38138 —
Columbia Medical Group, The Frist Clinic Nashville Tennessee 37203 —
Nashville Medical Research Institute Nashville Tennessee 37205 —
Nashville Gastrointestinal Specialists, Inc Nashville Tennessee 37211 —
The North Texas Research Institute Arlington Texas 76012 —
Baylor University Medical Center Dallas Texas 75246 —
Kelsey Research Foundation Houston Texas 77005 —
Research Specialists of Texas Houston Texas 77030 —
Metropolitan Research Fairfax Virginia 22031 —
Digestive and Liver Disease Specialists Norfolk Virginia 23502 —
Liver Institute of Virginia Richmond Virginia 23249 —
Virginia Mason Medical Center, Digestive Disease Institute Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01371578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01371578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →